In June 2023, Premier Integrated Labs, formerly known as Pantai Premier Pathology, celebrated a momentous occasion with its official launch, marking a significant milestone. We take great pride in being the quadruple-crowned clinical laboratory in Malaysia, having attained the distinguished accreditations of the College of American Pathology (CAP), MS ISO 15189, Malaysian Society for Quality in Health (MSQH) and Joint Commission International (JCI).

Category Archives: Newsroom

  HomePremier Integrated Labs  |  Newsroom

Official Collaboration Between Premier Integrated Labs and Axon Alpha Specialist Centre

Premier Integrated Labs & Axon Alpha Specialist Centre Strengthening Diagnostic Excellence for Enhanced Patient Care

Premier Integrated Labs proudly celebrated its official collaboration with Axon Alpha Specialist Centre through the signing of a Memorandum of Understanding (MoU) at Pantai Hospital Kuala Lumpur on 23rd October 2024. This strategic partnership marks a significant step in strengthening diagnostic support and enhancing patient care.

By combining Premier Integrated Labs’ advanced laboratory expertise with Axon Alpha’s specialized medical services, we aim to provide seamless and efficient diagnostic solutions, ensuring timely and accurate results for better clinical decisions. This collaboration underscores our shared commitment to delivering high-quality healthcare, improving patient outcomes, and elevating the overall healthcare experience.

We look forward to a strong and fruitful partnership with Axon Alpha Specialist Centre, working together to bring innovative and reliable medical solutions to the communities we serve.

 

MoU between Premier Integrated Labs, Genomax Technologies, and Veracyte

Premier Integrated Labs, Genomax Technologies, and Veracyte collaborate to transform breast cancer care in Malaysia through a Memorandum of Understanding signing

The signing of the Memorandum of Understanding (MoU) between Premier Integrated Labs, Genomax Technologies, and Veracyte marks a significant milestone in advancing breast cancer care in Malaysia. The MoU was signed by Mr. Sayyidi Hamzi, Senior Manager of Premier Integrated Labs, Mr. Wong Lin Sheng, Managing Director of Genomax Technologies and Dr. Bertrand Farnault, Commercial Director of IVD at Veracyte. This collaboration introduces the Prosigna® Breast Cancer Assay (PAM50), making Premier Integrated Labs the sole local service provider of this cutting-edge diagnostic tool in Southeast Asia. We are driven by the belief that early, precise diagnosis is essential to improving patient outcomes.

Through this partnership, we are equipping healthcare providers with the latest genomic insights, empowering them to offer personalized treatment strategies to breast cancer patients. Together, we are transforming breast cancer care and helping patients make informed decisions about their treatment options.

Univants of Healthcare Excellence Award Ceremony

Univants of Healthcare Excellence 2024 Top Elite Winner

An awards ceremony hosted by UNIVANTS was held on 15th August 2024 at Le Meridien Kuala Lumpur, and was graced by distinguished guests including YB Datuk Seri Dr Dzulkefly Ahmad, Minister of Health Malaysia and Dato’ Indera Dr. Nor Azimi binti Yunus, Deputy Director General of Health among many other VIPs.

 

This recognition celebrates Premier Integrated Labs as one of the three elite top winners, alongside winners from Canada and the United States for our pioneering work in the early detection of metabolic-dysfunction-associated steatotic liver disease using FIB-4 and our dedication to advancing diagnostic capabilities and improving patient outcomes. This award highlights our commitment to advancing diagnostic capabilities and improving patient outcomes with cutting-edge medical technology.

Premier Integrated Labs Leads Strategic Partnership in Malaysia ,Transforming Chronic Kidney Disease Care

Empowering Early Detection and Intervention to Combat CKD’s Growing Impact

On 7th May 2024, Premier Integrated Labs entered a strategic partnership to revolutionize chronic kidney disease (CKD) care through the use of advanced digital solutions such as the MyCKD CPG app and the Kidney Failure Risk Equation. This strategic partnership includes AstraZeneca, the Malaysian Society of Nephrology (MSN), the Malaysian Association of Clinical Biochemists (MACB), Chapter of Chemical Pathology and Metabolic Medicine, College of Pathologists, Academy of Medicine of Malaysia (CPMM, CPath AMM), Innoquest Pathology, Lablink Medical Laboratory, and Sunway Medical Centre Laboratory.

In Malaysia, over five million people have CKD, but only 5% are aware of it. More than 51,000 Malaysians currently live with end-stage renal disease (ESRD), leading to significant healthcare expenses. The rise in CKD is linked to factors like diabetes and hypertension. Early detection and intervention are vital for reducing complications and mortality. This partnership aims to promote proactive measures for CKD detection and intervention.

Memorandum of Understanding (MoU) between Premier Integrated Labs with Gene Solutions

PIL & Gene Solutions MoU

On April 25th, 2024, Premier Integrated Labs (PIL) and Gene Solutions came together for the signing of a memorandum of understanding. This partnership marks the collaboration of two leading entities, assured to transform cancer care through pioneering technology and innovative solutions.

PIL and Gene Solutions aim to redefine early cancer detection through Multi Cancer Early Detection (MCED) techniques and expand the scope of cancer care by implementing minimal residual disease monitoring. Leveraging Gene Solutions’ cutting-edge SPOT-MAS and K-TRACK tests, our combined efforts promise to reshape the healthcare landscape and improve patient outcomes.

This collaboration represents a union of expertise, innovation, and unwavering commitment to excellence. By combining PIL’s extensive diagnostic experience with Gene Solutions’ state-of-the-art technology, we aim to transform cancer care and make a meaningful difference in the lives of patients battling this disease.

Together, we aim to advance cancer care, striving for breakthroughs that make a tangible impact in the fight against cancer.

1 2 3 4 … 7